journal
Journals Assay and Drug Development Tec...

Assay and Drug Development Technologies

https://read.qxmd.com/read/37801663/illuminating-insights-clinical-study-harnessing-pharmacoscintigraphy-for-permeation-study-of-radiolabeled-nimesulide-topical-formulation-in-healthy-human-volunteers
#21
JOURNAL ARTICLE
Nitin Sharma, Kushagra Khanna, Neeraj Kumar, Ritu Karwasra, Ashok Kumar Janakiraman, Mogana Sundari Rajagopal
An alternative to oral administration for the delivery of therapeutic substances is the topical route, which frequently has comparable efficacy but may have a better tolerability profile. Gamma scintigraphy is a noninvasive technique that involves the application of radioactive substances to conduct biodistribution studies of therapeutic substances delivered through various routes. Nimesulide (NSD) was radiolabeled with technetium pertechnetate (Technetium99m [99m Tc]) and this radiolabeled drug complex (99m Tc-NSD) was used to prepare a topical gel formulation...
October 6, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37831909/formulation-and-characterization-of-nanoparticulate-drug-carrier-system-for-lacidipine
#22
JOURNAL ARTICLE
Ashveta Anant Dessai, Mrunali Navin Kantak, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Rupesh Kalidas Shirodkar
Lacidipine, a calcium channel antagonist, is primarily used to treat hypertension. It is classified as a Biopharmaceutics Classification System Class II drug and exhibits an oral bioavailability of 10% due to its extensive hepatic first-pass metabolism. This research study focused on formulating lacidipine-loaded cubosomal nanovesicles developed into rapidly dissolving oral films as an alternative to overcome the downsides faced by conventional antihypertensive therapy. Lacidipine-loaded cubosomes were prepared utilizing a top-down technique using lipid and surfactant and were further developed into fast dissolving oral films...
October 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37831908/quality-by-design-approach-for-optimization-of-microbial-and-ph-triggered-colon-targeted-tablet-formulation-using-carboxymethyl-tamarind-gum
#23
JOURNAL ARTICLE
Jaymin Patel, Kaushika Patel, Shreeraj Shah
ABSTRACT The purpose of this study was to apply the quality by design (QbD) approach in the development of a microbial and pH-triggered colon-targeted budesonide tablet. A retrospective research strategy was used to select various polysaccharide-based natural gums such as tamarind gum, gellan gum, karaya gum, gum ghutti, and khaya gum, which were then evaluated for their effectiveness in microbial degradation and targeting the colon. Viscosity profiles were generated in the presence of a prebiotic culture medium prepared by using the Velgut capsule that mimicked the impact of 4% rat cecal content and helpful in screening of natural polymer...
October 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37831907/determination-of-the-toxicity-preferences-of-ocular-drug-delivery-system-by-comparing-two-different-toxicity-bioassays
#24
JOURNAL ARTICLE
Burcu Uner, Meltem Ezgi Durgun, Samet Ozdemir, Cetin Tas, Melike Uner, Yildiz Ozsoy
Ocular drug delivery methods are highly favored for boosting bioavailability, patient compliance, and lower adverse effects and dose frequency. In addition to preventing adverse effects from the active ingredient, the parts of drug delivery systems must be nontoxic and nonallergic as well. Mitochondrial toxicity test (MTT) and Hen's egg chorioallantois membrane (HET-CAM) assay are the most often utilized tests based on this dilemma. The toxicity of loteprednol etabonate loaded solid lipid nanoparticles, lipid nanostructured carriers, and nanoemulsion were compared...
October 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37768806/adjusting-the-fitting-of-fluorescence-based-dose-response-kinase-inhibition-assay-to-account-for-fluorescent-inhibitors
#25
JOURNAL ARTICLE
Guillaume A Petit
Fluorescence is routinely used to monitor kinase inhibition in commercial assays. Occasionally fluorescent compounds can interfere with the fluorescent reading. To address this issue, the problematic data are usually truncated to improve the fit, however, this approach raises ethical and reproducibility concerns. Instead, it is suggested to adjust the fitting formula, to account for the autofluorescence of the compounds and improve the fit of the data compared with a naive approach. Finally, it was noticed that truncating the data can result in a small underestimation of the IC50 values and should therefore be used carefully...
September 28, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37682969/exploration-of-the-mechanism-of-shengxian-decoction-against-chronic-obstructive-pulmonary-disease-based-on-network-pharmacology-and-experimental-verification
#26
JOURNAL ARTICLE
Yifei Chen, Yiming Wang, Zheng Li, Jing Jing, De Jiang, Xiaoxia Yuan, Fengsen Li
Shengxian decoction (SXT) is clinically used in chronic obstructive pulmonary disease (COPD) treatment. This study aimed to explore the mechanism and target genes of SXT acting on COPD. Differentially expressed genes (DEGs) between COPD and controls were identified and then performed enrichment analysis. The effective active compounds and corresponding target genes were obtained from the traditional Chinese medicine systems pharmacology database. We also compiled COPD related genes from the GeneCards database...
September 8, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37682343/development-and-method-validation-of-design-of-experiments-optimized-tablet-formulation-for-simultaneous-detection-of-exemestane-and-everolimus
#27
JOURNAL ARTICLE
Akshay Kumar, Balak Das Kurmi, Dilpreet Singh
The development and analysis of pharmaceutical formulations often involves the determination of multiple active ingredients in a dosage form. The aim of the present study is to develop a convenient method for simultaneous estimation of Exemestane (EXE) and Everolimus (EVE) in bulk and in systemically designed tablet dosage form. Methanol was used as a solvent for developing linear curves and validated in terms of various parameters, such as selectivity, sensitivity, linearity, precision, accuracy, and robustness...
September 8, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37672608/-correction-to-enhanced-cytotoxic-activity-of-6-mercaptopurine-loaded-solid-lipid-nanoparticles-in-hepatic-cancer-treatment-by-ergin-et-al-assay-drug-dev-technol-2023-21-5-212-221-doi-10-1089-adt-2023-007
#28
(no author information available yet)
No abstract text is available yet for this article.
September 6, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37668595/drug-repurposing-patent-applications-april-june-2023
#29
JOURNAL ARTICLE
Hermann A M Mucke
No abstract text is available yet for this article.
September 1, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37439798/design-synthesis-molecular-docking-and-biological-evaluation-of-isatin-based-fused-heterocycles-as-epidermal-growth-factor-receptor-inhibitors
#30
JOURNAL ARTICLE
Ankush Kumar, Bhupinder Kumar, Rohit Bhatia
ABSTRACT A series of isatin-based fused heterocycles were designed, synthesized, and evaluated for anticancer activity against four cancer cell lines: MCF-7, MDA-MB-231, A549, and HL-60. Among them, Q3 and T4 were found to be potent anticancer agents. Furthermore, two compounds Q3 and T4 were selected for epidermal growth factor receptor (EGFR) inhibitory activity. Two compounds Q3 and T4 were found to be most potent EGFR inhibitors with IC50 of 0.22 ± 0.10 and 0.19 ± 0...
July 12, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37428562/twist1-promotes-colorectal-carcinoma-stemness-and-oxaliplatin-resistance-by-activating-microfibrillar-associated-protein-2
#31
JOURNAL ARTICLE
Ying Liu, Minhan Chen, Bo Wu
Colorectal carcinoma (CRC) is a fatal disease and ranks as the third most prevalent cancer globally. Stemness and drug resistance are the main causes of tumor recurrence in CRC. This study attempted to probe the impact of TWIST1 on CRC stemness and resistance to oxaliplatin and to uncover the underlying regulatory mechanism of TWIST1. mRNA expression data from The Cancer Genome Atlas-CRC were subjected to differential analysis. The target gene in the study was determined according to literature citation. ChIPBase was utilized to predict likely targets downstream of the target gene...
July 10, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37417972/enhanced-cytotoxic-activity-of-6-mercaptopurine-loaded-solid-lipid-nanoparticles-in-hepatic-cancer-treatment
#32
JOURNAL ARTICLE
Ahmet Doğan Ergin, Çağatay Oltulu, Büşra Koç
6-Mercaptopurine (6-MCP) is an antiproliferative purine analog used in acute lymphoblastic leukemia, non-Hodgkin lymphoma, and inflammatory bowel disease (Crohn's disease, ulcerative colitis). Although 6-MCP has the great therapeutic potential for cancer and immunosuppressant-related diseases, 6-MCP is not readily soluble in water, presents a high first-pass effect, short half-life (0.5-1.5 h), and implies a low bioavailability (16%). On the contrary, solid lipid nanoparticles (SLNs) are prepared from solid lipids at room temperature and body temperature...
July 7, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37459589/rosalind-franklin-society-proudly-announces-the-2022-award-recipient-for-assay-and-drug-development-technologies
#33
JOURNAL ARTICLE
Anaelle da Costa
No abstract text is available yet for this article.
July 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37285190/biosensor-assays-types-and-their-roles-toward-ligand-receptor-interactions-in-drug-discovery
#34
JOURNAL ARTICLE
Garima Gupta, Kanupriya Jha, Sarika Chaudhary
Ligand-receptor interactions (LRIs) are the basis for all the biological processes taking place in living cells and have been exploited to develop and implement in medical field a number of highly sensitive biosensors for the detection of various biomarkers in complex biological fluids. Drug-target interactions, one of the LRIs, are important to understand the biological processes that further help in developing new and better therapeutic molecules. Biosensors based on these interactions give us an idea for the need of modification of existing drugs or to develop new drugs...
June 6, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37229625/losartan-plays-a-fungistatic-and-fungicidal-activity-against-candida-albicans-biofilms-drug-repurposing-for-localized-candidosis
#35
JOURNAL ARTICLE
Vanessa Soares Lara, Rafaela Alves da Silva, Tatiane Ponteado Ferrari, Carlos Ferreira Dos Santos, Sandra Helena Penha de Oliveira
Candidosis is one of the most frequent opportunistic infections and exhibits variable clinical presentations, including oral localized forms. Drugs affecting the renin-angiotensin system targets inhibit secreted aspartic proteases from Candida albicans . The objective of the study was to evaluate whether losartan has antimicrobial action against C. albicans biofilms. Biofilms were treated with losartan or aliskiren (for comparison) for 24 h. Metabolic activity of viable cells and growth inhibition of C...
May 25, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37192485/drug-repurposing-patent-applications-january-march-2023
#36
JOURNAL ARTICLE
Hermann A M Mucke
No abstract text is available yet for this article.
May 16, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37083490/doxorubicin-conjugates-an-efficient-approach-for-enhanced-therapeutic-efficacy-with-reduced-side-effects
#37
JOURNAL ARTICLE
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Amrinder Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Continuous drug delivery modification is the scientific approach and is a basic need for the efficient therapeutic efficacy of active drug molecules. Polymer-drug conjugates have long been a hallmark of the drug delivery sector, with various conjugates on the market or in clinical trials. Improved drug solubilization, extended blood circulation, decreased immunogenicity, controlled release behavior, and increased safety are the advantages of conjugating drugs to the polymeric carrier like polyethylene glycol (PEG)...
April 20, 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/37036476/high-throughput-ultra-performance-liquid-chromatography-tandem-mass-spectrometry-method-validation-for-the-estimation-of-atorvastatin-and-active-metabolites-in-human-plasma
#38
JOURNAL ARTICLE
Nikhil Agrawal, Amit Mittal
A highly selective, sensitive, rugged, and rapid ultra high-performance liquid chromatography-tandem mass spectrometry method (UPLC-MS/MS) is optimized and validated for reliable quantification of atorvastatin (ATR) and its active metabolites, 2-hydroxy atorvastatin (2-ATR) and 4-hydroxy atorvastatin (4-ATR) in human plasma using atorvastatin-D5 (ATR-D5), 2-hydroxy atorvastatin-D5 (2-ATR-D5), and 4-hydroxy atorvastatin-D5 (4-ATR-D5) as deuterium-labeled internal standards (ISTDs), respectively. Isocratic mode chromatographic separation was used with a reverse-phase C18 Symmetry Shield (150 × 4...
April 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/36976774/oral-gastroretentive-film-of-lacidipine-for-the-treatment-of-gastroparesis
#39
JOURNAL ARTICLE
Mrunali Navin Kantak, Lalit Kumar, Prashant Jivaji Bhide, Rupesh Kalidas Shirodkar
The research work was aimed to formulate and evaluate gastroretentive mucoadhesive film of calcium channel blocker, Lacidipine for treatment of gastroparesis. Box-Behnken design was used for preparation of optimized formulation using solvent casting method. In this design, different concentrations of mucoadhesive polymers HPMC E15, Eudragit RL100, and Eudragit RS100 were considered as independent variables and its effect on responses like percent drug release, swelling index at 12 h, and folding endurance of the film were examined...
April 2023: Assay and Drug Development Technologies
https://read.qxmd.com/read/36999897/validation-of-a-novel-supercritical-fluid-extractor-dryer-combo-instrument
#40
JOURNAL ARTICLE
Mritunjay Kumar, Yash Sharma, Kanak Chahar, Lakshmi Kumari, Lopamudra Mishra, Preeti Patel, Dilpreet Singh, Balak Das Kurmi
The current pharmaceutical manufacturing scenario involves different techniques for the processing of materials. For example, the extraction unit is one of the essential aspects of plant-based pharmaceuticals. Recently, various kinds of extraction techniques have been used for analytical and preparative scales; among them, a supercritical fluid extractor (SCFE) is the most widely used technique for extraction. It is used for an extensive range of crude drugs and can be possible with the help of SCFE by varying temperature/pressure...
March 30, 2023: Assay and Drug Development Technologies
journal
journal
40248
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.